Join to view full profile
101 The City Dr SOrange, CA 92868
Phone+1 888-264-1533
Dr. Baskin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Avi Baskin is a urologist based in Orange, CA, who graduated from the David Geffen School of Medicine at UCLA in 2017. His research contributions include several publications focusing on various urologic topics, such as penile cancer survivorship and the geographic distribution of urologic services. Some of his work has been published in reputable journals like European Urology Oncology and Urology Practice, with one of his studies on the genomic landscape of prostate cancer being notably cited multiple times in other publications.
Education & Training
University of California (San Francisco)Residency, Urology, 2017 - 2023
David Geffen School of Medicine at UCLAClass of 2017
Certifications & Licensure
CA State Medical License 2018 - 2028
TN State Medical License 2022 - 2026
Publications & Presentations
PubMed
- Caution in Interpreting Survival After for Salvage Focal Therapy vs Salvage Radical Prostatectomy.Avi S Baskin, Michael A Daneshvar
JAMA Oncology. 2026-07-01 - Penile Cancer Survivorship: Research Gaps in Psychosocial Health and Sexual Quality of Life.Cameron J Britton, Omar Almidani, Avi S Baskin, Chad Ritch, Omer Raheem
European Urology Oncology. 2026-02-01 - 1 citationsReadability of Public-Facing Urologic Oncology Trial Summaries on ClinicalTrials.gov.Avi S Baskin, Cameron J Britton, Lan Anh Sumner Galloway, Daniel D Joyce
Urology Practice. 2025-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










